Martensen IP’s Chad G. Clark, along with ClearMark Founder Alison Sathe, will provide insights on how medical technology companies should use their intellectual property and regulatory strategies to advance internal innovation in an informative online session on December 7, 2020 from 11:00 a.m. to 12:00 p.m. MST.
Sponsored by BioOhio, the event is part of its FDA MedTech & Pharma Regulatory Series.
Medical technology companies must operate and succeed in a challenging regulatory environment that is populated by innovative and well-funded competitors. In such an environment, having innovation-focused intellectual property and regulatory strategies is key to success.
The process of building an intellectual property strategy can help companies zero in on their most powerful contributions to the marketplace and establish means of exploiting and protecting those contributions. Meanwhile, because of the regulatory lead times involved in bringing new medical products to market, a forward-looking regulatory strategy is critical to making those potential contributions a reality. Together, coordinated IP and regulatory strategies can ensure that innovation can be translated into success by synchronizing goals and timelines.
Don’t miss this information-packed event!
Monday, December 7, 2020
11:00 a.m. to 12:00 p.m. MST
Who Should Attend?
This session will benefit anyone who has a role in crafting, implementing, overseeing or supporting their company’s IP strategy.